FDA Inspection
Ali Guerami, MDAli Guerami, MD – FDA Inspection, Apr 1, 2010
Record Details
This FDA Inspection record concerns Ali Guerami, MD, with an inspection on April 1, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Ali Guerami, MD
- Inspection Date
- April 1, 2010
- Product Type
- Biologics
View Company Profile
ID · e3532fdc-1c66-4304-8241-034ae96dc2ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 654471
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.47(d)Departures: recording and justifying
- 21 CFR 1271.55(d)(1)(iii)Documentation--determination, by whom, date
- 21 CFR 1271.250(c)Documentation of donor eligibility
- 21 CFR 1271.320(b)Available for review and copying by FDA
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ali Guerami, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 9, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Ali Guerami, MD
- FDA Inspection 793834 - 2012-08-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.